Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm,Prostatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01640262
What this trial is testing

Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup

Who this might be right for
Prostatic Neoplasms
Copenhagen University Hospital at Herlev 170
Very early researchUnknownNCT04113005
What this trial is testing

Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

Who this might be right for
Castrate Resistance Prostate Cancer
Sunnybrook Health Sciences Centre 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04536805
What this trial is testing

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

Who this might be right for
Prostate Cancer
Institut Cancerologie de l'Ouest 44
Large-scale testing (Phase 3)Study completedNCT02677896
What this trial is testing

Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 1,150
Testing effectiveness (Phase 2)Study completedNCT00020254
What this trial is testing

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT01751737
What this trial is testing

Choline PET/CT and MRI for Targeted Prostate Biopsy

Who this might be right for
Prostate Cancer
University of Michigan 63
Early research (Phase 1)Study completedNCT02826772
What this trial is testing

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Suzhou Kintor Pharmaceutical Inc, 40
Not applicableStudy completedNCT02346253
What this trial is testing

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Stanford University 146
Testing effectiveness (Phase 2)UnknownNCT00411853
What this trial is testing

Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

Who this might be right for
Hormone Refractory Prostate Cancer
Sheba Medical Center 60
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableActive Not RecruitingNCT03998657
What this trial is testing

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Who this might be right for
Prostate Cancer
InSightec 14
Large-scale testing (Phase 3)Active Not RecruitingNCT02319837
What this trial is testing

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Who this might be right for
Hormone Sensitive Prostate CancerProstate CancerCancer of the Prostate
Pfizer 1,068
Not applicableStudy completedNCT02702453
What this trial is testing

True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners

Who this might be right for
Sexual DisfunctionProstate Cancer
University of Michigan 251
Early research (Phase 1)Study completedNCT01017939
What this trial is testing

A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 34
Early research (Phase 1)Study completedNCT02285101
What this trial is testing

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

Who this might be right for
MelanomaProstate Adenocarcinoma
Bio-Cancer Treatment International Limited 23
Testing effectiveness (Phase 2)UnknownNCT05249712
What this trial is testing

Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Early research (Phase 1)Study completedNCT02730975
What this trial is testing

Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 42
Not applicableStudy completedNCT02264379
What this trial is testing

Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

Who this might be right for
Oligometastatic DiseaseProstate Cancer
Technische Universität Dresden 73
Early research (Phase 1)Looking for participantsNCT06879041
What this trial is testing

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
AstraZeneca 136
Not applicableTemporarily pausedNCT05820633
What this trial is testing

Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.

Who this might be right for
Prostate CancerNode; ProstateRadiotherapy Side Effect
CHU de Quebec-Universite Laval 500
Next Page